CLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New Products

 

Miami, FL--(February 2, 2021) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on CLS Holdings, Inc. (OTCQB: CLSH), (CSE: CLSH)

 

CLS Holdings, Inc. (OTCQB: CLSH) just announced that City Trees, the Company's manufacturing subsidiary is now offering 5 new distillate blends that are available in disposable vape pens, cartridges, and refill oil applicators. 

 

CLS Holdings, Inc. (OTCQB: CLSH) by the numbers:

  • Revenue for the six months ending November 30, 2020 came in at $8,688,758.  If this was repeated for the next two quarters, the company would break $17 million in sales.

 

  • Revenue for the quarter ending November 30, 2020 of $4,907,889 represented a 61% increase over the same quarter in 2019, and a 29.8% increase over the first fiscal Q in 2021.

 

  • Assets reported on its most recent quarter came in at $14,399,741.

 

  • Shares Outstanding: $126,571,416

 

  • Market Cap: $20,238,769

 

CLSH may not be at these levels much longer.

 

 

CLS Holdings, Inc. (OTCQB: CLSH) anticipates a continued rise in market penetration and growth throughout the rest of 2021.

 

City Trees currently has over 70% market penetration and the brand is poised to continue growing market share and strengthen its position as Nevada's premier extract producer with the release of these new products.

 

 

 

 

 

This could be the biggest play we see in the cannabis space this year.

 

The new vape products come as the result of months of market research on in-demand strains and flavor profiles, with each blend serving a unique segment of consumers, while also allowing for the brand to develop custom creations. To address market demand for fruit-forward flavors, City Trees' new Mango Haze blend brings a unique tropical profile. The brand also sought to add variety with popular exotic strain blends, including GMO, Cherry Cola, and LV Confidential - a localized take on the popular strain, LA Confidential. To best serve the connoisseur market, the brand's new Gasolina blend brings recognizable flavors modelled after a variety of classic cannabis strains.

 

 

"Each of these new products does an incredible job of providing options that our existing consumers were looking for according to our research, from of-the-moment strains to custom, flavor-driven experiences" said Company President and COO Andrew Glashow. "Seeing how successful our rebrand was in 2020 gave us the ability to refocus efforts on product innovation, and these new blends are the first of many new expansions for the brand catalog."

 

 

Other Companies in the news and featured on EmergingGrowth.com

 

Sundial Growers, Inc.

Shares of Sundial Growers (NASDAQ: SNDL) first began to develop steam on November 6, 2020 with an article from SeekingAlpha.com pushed the stock up and down 100% in one trading session.  After a combination of 41 press releases and third-party articles, the stock realized two things.  A 385% gain, and a revisit of two support pivots of which the stock was unable to break in May and June of 2020.   

 

Have a look at CLS Holdings, Inc. (OTCQB: CLSH) With 5 new products just released, this could be the catalyst that brings the stock to trade among the majors in the space. 

Innovation Pharmaceuticals, Inc.

In the past two trading sessions, we watched Innovation Pharmaceuticals, Inc. (OTCQB: IPIX) run 50% and engulf its previous resistance of .299.  A number it could not crack with two previous attempts.  Friday's announcement obviously continued the momentum into this week, but be careful of that big toping tail the stock left after it touched .35.

 

Check out CLS Holdings, Inc. (OTCQB: CLSH) which is trading at price to sales ratio of just over 1, with some pretty big growth that's being overlooked.

 

Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. (OTC Pink: SBFM) gave back 57% in what seemed like a healthy pullback last week and appears to be making its way back up in price.  Nest resistance is at .17 but last week's topping tail on the weekly chart might prove that difficult. 

 

Watch CLS Holdings, Inc. (OTCQB: CLSH).  The company anticipates a continued rise in market penetration and growth throughout the rest of 2021.

 

Enzolytics, Inc.

 

Shares of Enzolytics, Inc. (OTC Pink: ENZC) showed some promise today after the announcement of the discovery of seven newly identified conserved target sites on the HIV virus.  A SeekingAlpha.com article on January 27th, seemed to be responsible for its 100% rise and subsequent 50% fall.  Maybe another SA writer will take an interest and put them over the top.

 

In the meantime, Check out CLS Holdings, Inc. (OTCQB: CLSH).  This could be the biggest play in the cannabis space this year.

 

 

About CLS Holdings USA, Inc.

 

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. https://www.clsholdingsinc.com/

Twitter: @CLSHoldingsUSA

 

 

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com

 

 

 

Total Addressable Market, or TAM, estimate is based on Nevada estimated sales data provided by BDS Analytics for December 2020. This estimate is based upon predicted results, is uncertain and involves known and unknown uncertainties and other factors that may cause actual results to be materially different from this estimate.

Figure reported as of January 28, 2021. Additional sales may increase this total for the remainder of January 2021.

 

Forward Looking Statements

 

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the impact of the COVID-19 virus on our business, the results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the effect of our initiatives to expand market share and achieve growth during and following the pandemic, results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material.  In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.  We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

 

Contact Information:

 

Corporate:

Chairman and CEO

Jeff Binder

 

President and COO

Andrew Glashow

 

888-438-9132

 

Investor Relations:

investors@clsholdingsinc.com

 

Source: CLS Holdings USA, Inc.

 

 

About EmergingGrowth.com

Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

 

All information and material contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable and / or provided to EmergingGrowth.com by a third party, but not guaranteed to be accurate or all-inclusive. All material contained within this article, is for informational purposes only, and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article.  EmergingGrowth.com has been compensated ten thousand five hundred dollars in consideration for its work with CLS Holdings USA, Inc. EmergingGrowth.com has received additional past compensation, details about which can be found in our full disclosure, which can be found here, https://emerginggrowth.com/2574-68272/ You can easily lose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

 

 

 

CONTACT:

Company: EmergingGrowth.com - http://www.EmergingGrowth.com

Contact Email: info@EmergingGrowth.com

SOURCE: EmergingGrowth.com

Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Innovation Pharmaceuticals (CE) Charts.
Innovation Pharmaceuticals (CE) (USOTC:IPIX)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Innovation Pharmaceuticals (CE) Charts.